IOVANCE BIOTHERAPEUTICS, INC. Operating Cash Flow
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Operating Cash Flow of -$132.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$60.84M.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$72.07M.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$52.56M.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$78.70M.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$302.41M.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$352.98M.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$361.82M.
- IOVANCE BIOTHERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$292.76M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 45 month | Net Cash Provided by (Used in) Operating Activities 48 month | Net Cash Provided by (Used in) Operating Activities 51 month | Net Cash Provided by (Used in) Operating Activities 54 month | Net Cash Provided by (Used in) Operating Activities 57 month | Net Cash Provided by (Used in) Operating Activities 60 month | Net Cash Provided by (Used in) Operating Activities 63 month | Net Cash Provided by (Used in) Operating Activities 66 month | Net Cash Provided by (Used in) Operating Activities 69 month | Net Cash Provided by (Used in) Operating Activities 72 month | Net Cash Provided by (Used in) Operating Activities 78 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$60.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$132.91M 10-Q · filed 2026-08-06 | -$185.48M derived: sum of 3 quarters · filed 2026-08-06 | -$264.18M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2026-03-31 | -$72.07M 10-Q · filed 2026-05-07 | -$124.64M derived: sum of 2 quarters · filed 2026-05-07 | -$203.34M derived: sum of 3 quarters · filed 2026-05-07 | -$270.79M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2025-12-31 | -$52.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$131.27M derived: sum of 2 quarters · filed 2026-02-24 | -$198.71M derived: sum of 3 quarters · filed 2026-08-06 | -$302.41M 10-K · filed 2026-02-24 | ||||||||||||
| 2025-09-30 | -$78.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$146.15M derived: sum of 2 quarters · filed 2026-08-06 | -$249.84M 10-Q · filed 2025-11-06 | -$323.14M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2025-06-30 | -$67.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$171.14M 10-Q · filed 2026-08-06 | -$244.44M derived: sum of 3 quarters · filed 2026-08-06 | -$303.41M derived: sum of 4 quarters · filed 2026-08-06 | ||||||||||||
| 2025-03-31 | -$103.69M 10-Q · filed 2026-05-07 | -$176.99M derived: sum of 2 quarters · filed 2026-05-07 | -$235.96M derived: sum of 3 quarters · filed 2026-05-07 | -$334.39M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||||||
| 2024-12-31 | -$73.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$132.27M derived: sum of 2 quarters · filed 2026-02-24 | -$230.70M derived: sum of 3 quarters · filed 2026-02-24 | -$352.98M 10-K · filed 2026-02-24 | ||||||||||||
| 2024-09-30 | -$58.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$157.40M derived: sum of 2 quarters · filed 2025-11-06 | -$279.68M 10-Q · filed 2025-11-06 | -$363.65M derived: sum of 4 quarters · filed 2026-02-24 | ||||||||||||
| 2024-06-30 | -$98.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$220.71M 10-Q · filed 2025-08-07 | -$304.68M derived: sum of 3 quarters · filed 2026-02-24 | -$388.76M derived: sum of 4 quarters · filed 2026-02-24 | ||||||||||||
| 2024-03-31 | -$122.28M 10-Q · filed 2025-05-08 | -$206.25M derived: sum of 2 quarters · filed 2026-02-24 | -$290.33M derived: sum of 3 quarters · filed 2026-02-24 | -$384.28M derived: sum of 4 quarters · filed 2026-02-24 | ||||||||||||
| 2023-12-31 | -$83.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$168.05M derived: sum of 2 quarters · filed 2026-02-24 | -$262.00M derived: sum of 3 quarters · filed 2026-02-24 | -$361.82M 10-K · filed 2026-02-24 | ||||||||||||
| 2023-09-30 | -$84.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$178.03M derived: sum of 2 quarters · filed 2024-11-07 | -$277.85M 10-Q · filed 2024-11-07 | -$355.52M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2023-06-30 | -$93.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$193.77M 10-Q · filed 2024-08-08 | -$271.44M derived: sum of 3 quarters · filed 2025-02-27 | -$335.09M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2023-03-31 | -$99.81M 10-Q · filed 2024-05-09 | -$177.49M derived: sum of 2 quarters · filed 2025-02-27 | -$241.13M derived: sum of 3 quarters · filed 2025-02-27 | -$318.77M derived: sum of 4 quarters · filed 2025-02-27 | ||||||||||||
| 2022-12-31 | -$77.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$141.32M derived: sum of 2 quarters · filed 2025-02-27 | -$218.96M derived: sum of 3 quarters · filed 2025-02-27 | -$292.76M 10-K · filed 2025-02-27 | ||||||||||||
| 2022-09-30 | -$63.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$141.28M derived: sum of 2 quarters · filed 2023-11-07 | -$215.09M 10-Q · filed 2023-11-07 | -$268.94M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2022-06-30 | -$77.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$151.44M 10-Q · filed 2023-08-08 | -$205.29M derived: sum of 3 quarters · filed 2024-02-28 | -$262.98M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2022-03-31 | -$73.80M 10-Q · filed 2023-05-10 | -$127.65M derived: sum of 2 quarters · filed 2024-02-28 | -$185.34M derived: sum of 3 quarters · filed 2024-02-28 | -$239.35M derived: sum of 4 quarters · filed 2024-02-28 | ||||||||||||
| 2021-12-31 | -$53.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$111.54M derived: sum of 2 quarters · filed 2024-02-28 | -$165.55M derived: sum of 3 quarters · filed 2024-02-28 | -$227.94M 10-K · filed 2024-02-28 | ||||||||||||
| 2021-09-30 | -$57.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$111.70M derived: sum of 2 quarters · filed 2022-11-03 | -$174.09M 10-Q · filed 2022-11-03 | -$236.78M derived: sum of 4 quarters · filed 2023-02-28 | ||||||||||||
| 2021-06-30 | -$54.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$116.40M 10-Q · filed 2022-08-04 | -$179.09M derived: sum of 3 quarters · filed 2023-02-28 | -$219.61M derived: sum of 4 quarters · filed 2023-02-28 | ||||||||||||
| 2021-03-31 | -$62.39M 10-Q · filed 2022-05-05 | -$125.08M derived: sum of 2 quarters · filed 2023-02-28 | -$165.60M derived: sum of 3 quarters · filed 2023-02-28 | -$202.23M derived: sum of 4 quarters · filed 2023-02-28 | ||||||||||||
| 2020-12-31 | -$62.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$103.21M derived: sum of 2 quarters · filed 2023-02-28 | -$139.84M derived: sum of 3 quarters · filed 2023-02-28 | -$205.13M 10-K · filed 2023-02-28 | ||||||||||||
| 2020-09-30 | -$40.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$77.15M derived: sum of 2 quarters · filed 2021-11-04 | -$142.44M 10-Q · filed 2021-11-04 | -$196.26M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||
| 2020-06-30 | -$36.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$101.93M 10-Q · filed 2021-08-05 | -$155.75M derived: sum of 3 quarters · filed 2022-02-24 | -$197.93M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||
| 2020-03-31 | -$65.29M 10-Q · filed 2021-05-06 | -$119.11M derived: sum of 2 quarters · filed 2022-02-24 | -$161.30M derived: sum of 3 quarters · filed 2022-02-24 | -$195.09M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||
| 2019-12-31 | -$53.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$96.00M derived: sum of 2 quarters · filed 2022-02-24 | -$129.80M derived: sum of 3 quarters · filed 2022-02-24 | -$158.89M 10-K · filed 2022-02-24 | ||||||||||||
| 2019-09-30 | -$42.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$75.98M derived: sum of 2 quarters · filed 2020-11-05 | -$105.07M 10-Q · filed 2020-11-05 | -$136.62M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||
| 2019-06-30 | -$33.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$62.88M 10-Q · filed 2020-08-06 | -$94.43M derived: sum of 3 quarters · filed 2021-02-25 | -$122.36M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||
| 2019-03-31 | -$29.09M 10-Q · filed 2020-05-05 | -$60.64M derived: sum of 2 quarters · filed 2021-02-25 | -$88.57M derived: sum of 3 quarters · filed 2021-02-25 | -$112.49M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||
| 2018-12-31 | -$31.55M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$59.48M derived: sum of 2 quarters · filed 2021-02-25 | -$83.40M derived: sum of 3 quarters · filed 2021-02-25 | -$101.25M 10-K · filed 2021-02-25 | ||||||||||||
| 2018-09-30 | -$27.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$51.85M derived: sum of 2 quarters · filed 2019-11-04 | -$69.70M 10-Q · filed 2019-11-04 | -$90.66M derived: sum of 4 quarters · filed 2020-02-25 | ||||||||||||
| 2018-06-30 | -$23.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$41.77M 10-Q · filed 2019-08-01 | -$62.74M derived: sum of 3 quarters · filed 2020-02-25 | -$84.18M derived: sum of 4 quarters · filed 2020-02-25 | ||||||||||||
| 2018-03-31 | -$17.85M 10-Q · filed 2019-05-07 | -$38.81M derived: sum of 2 quarters · filed 2020-02-25 | -$60.26M derived: sum of 3 quarters · filed 2020-02-25 | -$77.75M derived: sum of 4 quarters · filed 2020-02-25 | ||||||||||||
| 2017-12-31 | -$20.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$42.41M derived: sum of 2 quarters · filed 2020-02-25 | -$59.91M derived: sum of 3 quarters · filed 2020-02-25 | -$78.71M 10-K · filed 2020-02-25 | ||||||||||||
| 2017-09-30 | -$21.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$38.94M derived: sum of 2 quarters · filed 2018-11-06 | -$57.74M 10-Q · filed 2018-11-06 | -$69.90M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||
| 2017-06-30 | -$17.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$36.30M 10-Q · filed 2018-08-07 | -$48.46M derived: sum of 3 quarters · filed 2019-02-28 | |||||||||||||
| 2017-03-31 | -$18.80M 10-Q · filed 2018-05-10 | -$30.96M derived: sum of 2 quarters · filed 2019-02-28 | ||||||||||||||
| 2016-12-31 | -$12.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$32.67M 10-K · filed 2019-02-28 | ||||||||||||||
| 2016-09-30 | -$20.51M 10-Q · filed 2017-11-02 | |||||||||||||||
| 2015-12-31 | -$18.38M 10-K · filed 2018-03-12 | |||||||||||||||
| 2015-03-31 | $3.46M 10-Q · filed 2015-05-11 | $17.41M derived: sum of 2 quarters · filed 2015-05-11 | $15.68M derived: sum of 3 quarters · filed 2015-05-11 | $14.36M derived: sum of 4 quarters · filed 2015-05-11 | ||||||||||||
| 2014-12-31 | $13.95M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $12.22M derived: sum of 2 quarters · filed 2015-03-16 | $10.90M derived: sum of 3 quarters · filed 2015-03-16 | $8.63M 10-K · filed 2015-03-16 | ||||||||||||
| 2014-09-30 | -$1.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$3.05M derived: sum of 2 quarters · filed 2014-11-13 | -$5.32M 10-Q · filed 2014-11-13 | -$7.57M derived: sum of 4 quarters · filed 2014-11-13 | ||||||||||||
| 2014-06-30 | -$1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$3.59M 10-Q · filed 2014-08-08 | -$5.84M derived: sum of 3 quarters · filed 2014-08-08 | -$6.27M derived: sum of 4 quarters · filed 2014-11-13 | ||||||||||||
| 2014-03-31 | -$2.27M 10-Q · filed 2014-05-14 | -$4.52M derived: sum of 2 quarters · filed 2014-05-14 | -$4.95M derived: sum of 3 quarters · filed 2014-11-13 | -$5.63M derived: sum of 4 quarters · filed 2014-11-13 | -$15.05M 10-Q · filed 2014-05-14 | |||||||||||
| 2013-12-31 | -$2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | -$2.68M derived: sum of 2 quarters · filed 2014-11-13 | -$3.36M derived: sum of 3 quarters · filed 2014-11-13 | -$3.66M 10-K · filed 2014-03-28 | -$12.79M 10-K · filed 2014-03-28 | |||||||||||
| 2013-09-30 | -$427.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$1.11M derived: sum of 2 quarters · filed 2014-11-13 | -$1.41M 10-Q · filed 2014-11-13 | -$1.41M derived: sum of 4 quarters · filed 2014-11-13 | -$10.53M 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | -$681.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$981.93K 10-Q · filed 2014-08-08 | -$981.93K 10-Q · filed 2013-10-23 | -$981.93K derived: sum of 3 quarters · filed 2014-08-08 | -$1.26M derived: sum of 4 quarters · filed 2014-08-08 | -$10.11M 10-Q · filed 2013-10-23 | ||||||||||
| 2013-03-31 | -$300.00K 10-Q · filed 2014-05-14 | -$300.00K derived: sum of 2 quarters · filed 2014-05-14 | -$580.74K derived: sum of 3 quarters · filed 2014-05-14 | -$1.78M derived: sum of 4 quarters · filed 2014-05-14 | -$9.42M 10-Q · filed 2013-10-23 | |||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | -$280.74K derived: sum of 2 quarters · filed 2014-03-28 | -$1.48M derived: sum of 3 quarters · filed 2014-03-28 | -$2.24M 10-K · filed 2014-03-28 | -$9.12M 10-K · filed 2013-09-23 | |||||||||||
| 2012-09-30 | -$280.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$1.48M derived: sum of 2 quarters · filed 2013-11-14 | -$2.24M 10-Q · filed 2013-11-14 | -$4.95M derived: sum of 4 quarters · filed 2013-11-14 | -$9.12M 10-Q · filed 2013-01-25 | |||||||||||
| 2012-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-23 | -$1.96M 10-Q · filed 2013-10-23 | -$4.67M derived: sum of 3 quarters · filed 2013-10-23 | -$6.32M derived: sum of 4 quarters · filed 2013-10-23 | -$8.84M 10-Q/A · filed 2012-09-10 | |||||||||||
| 2012-03-31 | -$760.22K 10-Q · filed 2013-10-23 | -$3.47M derived: sum of 2 quarters · filed 2013-10-23 | -$5.12M derived: sum of 3 quarters · filed 2013-10-23 | -$6.38M derived: sum of 4 quarters · filed 2013-10-23 | -$7.64M 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | -$2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23 | -$4.36M derived: sum of 2 quarters · filed 2013-09-23 | -$5.62M derived: sum of 3 quarters · filed 2013-09-23 | -$6.19M 10-K · filed 2013-09-23 | -$6.88M 10-K · filed 2012-03-30 | |||||||||||
| 2011-09-30 | -$1.65M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-25 | -$2.92M derived: sum of 2 quarters · filed 2013-01-25 | -$3.48M 10-Q · filed 2013-01-25 | -$3.85M derived: sum of 4 quarters · filed 2013-01-25 | -$4.17M 10-Q · filed 2011-11-21 | |||||||||||
| 2011-06-30 | -$1.27M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-10 | -$1.83M 10-Q/A · filed 2012-09-10 | -$1.83M 10-Q/A · filed 2011-09-01 | -$2.20M derived: sum of 3 quarters · filed 2012-09-10 | -$2.31M derived: sum of 4 quarters · filed 2012-09-10 | -$2.52M 10-Q/A · filed 2011-09-01 | ||||||||||
| 2011-03-31 | -$564.48K 10-Q · filed 2012-05-15 | -$934.07K derived: sum of 2 quarters · filed 2012-05-15 | -$1.05M derived: sum of 3 quarters · filed 2012-05-15 | |||||||||||||
| 2010-12-31 | -$369.59K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$482.91K derived: sum of 2 quarters · filed 2012-03-30 | -$620.80K 10-K · filed 2012-03-30 | |||||||||||||
| 2010-09-30 | -$113.32K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | -$251.21K 10-Q · filed 2011-11-21 | ||||||||||||||
| 2010-06-30 | -$137.89K 10-Q/A · filed 2011-09-01 | |||||||||||||||
| 2009-12-31 | -$14.45K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |